IL6 and depressive disorder: Inflammatory responses, characterized by elevated levels of proinflammatory cytokines such as interleukin‐6 (IL‐6) and tumor necrosis factor‐alpha (TNF‐α), have been implicated in the development of depression in cancer patients [8].